Next Article in Journal
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial
Next Article in Special Issue
The Group A Streptococcal Vaccine Candidate VAX-A1 Protects against Group B Streptococcus Infection via Cross-Reactive IgG Targeting Virulence Factor C5a Peptidase
Previous Article in Journal
Immunity after Vaccination against COVID-19
Previous Article in Special Issue
Streptococcus pyogenes: Pathogenesis and the Current Status of Vaccines
 
 
Article

Article Versions Notes

Vaccines 2023, 11(11), 1724; https://doi.org/10.3390/vaccines11111724
Action Date Notes Link
article xml file uploaded 17 November 2023 06:47 CET Original file -
article xml uploaded. 17 November 2023 06:47 CET Update https://www.mdpi.com/2076-393X/11/11/1724/xml
article pdf uploaded. 17 November 2023 06:47 CET Version of Record https://www.mdpi.com/2076-393X/11/11/1724/pdf
article supplementary file uploaded. 17 November 2023 06:47 CET - https://www.mdpi.com/2076-393X/11/11/1724#supplementary
article html file updated 17 November 2023 06:48 CET Original file https://www.mdpi.com/2076-393X/11/11/1724/html
Back to TopTop